During the past decade, ULSAM, EPE - Hospital de Santa Luzia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ULSAM, EPE - Hospital de Santa Luzia" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "ULSAM, EPE - Hospital de Santa Luzia" are "Arthroplasty, Replacement, Knee" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "ULSAM, EPE - Hospital de Santa Luzia" in a lesser frequency.

Most popular intervention types in "ULSAM, EPE - Hospital de Santa Luzia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Empagliflozin" (1 trials), "Enoxaparin 40 mg" (1 trials), "JNJ-70033093 100 mg" (1 trials) and "JNJ-70033093 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "ULSAM, EPE - Hospital de Santa Luzia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "ULSAM, EPE - Hospital de Santa Luzia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ULSAM, EPE - Hospital de Santa Luzia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ULSAM, EPE - Hospital de Santa Luzia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".